Raising Health From Surgeon to Biotech CEO with Jonathan Lim
Oct 15, 2024
Jonathan Lim, CEO of Erasca and former surgeon, shares his intriguing journey from the operating room to biotech leadership. He highlights the critical need for adaptability in the competitive biotech landscape, echoing Darwin's principles of evolution. Discussing advancements in cancer treatment, he showcases promising innovations like targeted therapies and immunotherapies. Lim's unique perspective intertwines the worlds of science and storytelling, revealing captivating insights on funding challenges and the shared complexities of biotech and Hollywood.
AI Snips
Chapters
Transcript
Episode notes
From Surgeon to CEO
- Jonathan Lim transitioned from surgeon to biotech CEO after a McKinsey stint.
- A patient of his father suggested this career path, leading him to a four-person startup.
Halozyme's Unlikely Start
- Lim joined Halozyme with three months of cash and no VC funding.
- Through a reverse merger with Global Yacht Services, they uplisted to NASDAQ.
Biotech's Darwinian Nature
- The biotech industry mirrors Darwinian evolution; companies must adapt to survive.
- This includes pivoting, securing funding, and attracting talent.